Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)

Blood (2008) 111 (10): 4979–4985.

https://doi.org/10.1182/blood-2007-09-110940

Published: 2008

Journal Articles

Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV

Sarah C. Darby, Sau Wan Kan, Rosemary J. Spooner, Paul L. F. Giangrande, Frank G. H. Hill, Charles R. M. Hay, Christine A. Lee, Christopher A. Ludlam, Michael Williams

Blood (2007) 110 (3): 815–825.

https://doi.org/10.1182/blood-2006-10-050435

Published: 2007

Includes: Supplemental data

Journal Articles

Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia

Anthony V. Moorman, Sue M. Richards, Mary Martineau, Kan Luk Cheung, Hazel M. Robinson, G. Reza Jalali, Zoë J. Broadfield, Rachel L. Harris, Kerry E. Taylor, Brenda E. S. Gibson, Ian M. Hann, Frank G. H. Hill, Sally E. Kinsey, Tim O. B. Eden, Christopher D. Mitchell, Christine J. Harrison, for the United Kingdom Medical Research Council's Childhood Leukaemia Working Party

Blood (2003) 102 (8): 2756–2762.

https://doi.org/10.1182/blood-2003-04-1128

Published: 2003

Journal Articles

Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease

M. Said Enayat, Andrea M. Guilliatt, Gurcharan K. Surdhar, P. Vincent Jenkins, K. John Pasi, Cheng Hock Toh, Michael D. Williams, Frank G. H. Hill

Blood (2001) 98 (3): 674–680.

https://doi.org/10.1182/blood.V98.3.674

Published: 2001

Journal Articles

Homozygous gene conversion in von Willebrand factor gene as a cause of type 3 von Willebrand disease and predisposition to inhibitor development

Gurcharan K. Surdhar, Mohammad S. Enayat, Sarah Lawson, Michael D. Williams, Frank G. H. Hill

Blood (2001) 98 (1): 248–250.

https://doi.org/10.1182/blood.V98.1.248

Published: 2001

Journal Articles

Bone marrow transplantation versus chemotherapy in the treatment of very high–risk childhood acute lymphoblastic leukemia in first remission: results from Medical Research Council UKALL X and XI

Kate A. Wheeler, Susan M. Richards, Clifford C. Bailey, Brenda Gibson, Ian M. Hann, Frank G. H. Hill, Judith M. Chessells

Blood (2000) 96 (7): 2412–2418.

https://doi.org/10.1182/blood.V96.7.2412

Published: 2000

Journal Articles

Characterization of B-cell lines established from two X-linked severe combined immunodeficiency patients: interleukin-15 binds to the B cells but is not internalized efficiently

S Kumaki, HD Ochs, M Timour, K Schooley, M Ahdieh, H Hill, K Sugamura, D Anderson, Q Zhu, D Cosman

Blood (1995) 86 (4): 1428–1436.

https://doi.org/10.1182/blood.V86.4.1428.bloodjournal8641428

Published: 1995

NARROW

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)

Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV

Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia

Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease

Homozygous gene conversion in von Willebrand factor gene as a cause of type 3 von Willebrand disease and predisposition to inhibitor development

Bone marrow transplantation versus chemotherapy in the treatment of very high–risk childhood acute lymphoblastic leukemia in first remission: results from Medical Research Council UKALL X and XI

Characterization of B-cell lines established from two X-linked severe combined immunodeficiency patients: interleukin-15 binds to the B cells but is not internalized efficiently

Email alerts

ASH Publications

American Society of Hematology

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)

Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV

Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia

Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease

Homozygous gene conversion in von Willebrand factor gene as a cause of type 3 von Willebrand disease and predisposition to inhibitor development

Bone marrow transplantation versus chemotherapy in the treatment of very high–risk childhood acute lymphoblastic leukemia in first remission: results from Medical Research Council UKALL X and XI

Characterization of B-cell lines established from two X-linked severe combined immunodeficiency patients: interleukin-15 binds to the B cells but is not internalized efficiently

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only